Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion (Q42201099)

18 October 2017

title

Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion (English)

1 reference

18 October 2017

1 reference

1 reference

1 reference

A Dornhorst

1

1 reference

18 October 2017

S H Powell

series ordinal

2

1 reference

18 October 2017

J Pensky

series ordinal

3

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 January 1985

1 reference

18 October 2017

1 reference

18 October 2017

volume

1

1 reference

18 October 2017

issue

8421

1 reference

18 October 2017

page(s)

123-126

1 reference

Thiazide-induced disturbances in carbohydrate, lipid, and potassium metabolism

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Impairment of glucose tolerance produced by diuretics and other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Hyperglycemia and glycosuria due to thiazide derivatives administered in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

The clinical information value of the glycosylated hemoglobin assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Correlation of urinary excretion of C-peptide with the integrated concentration and secretion rate of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Effect of diuretics on mouse blood sugar following single dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Hypertension, the Potassium Ion and Impaired Carbohydrate Tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Changes in the fasting blood sugar after hydrochlorothiazide and potassium supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Prevention of the Glucose Intolerance of Thiazide Diuretics by Maintenance of Body Potassium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Glucose tolerance and insulin responsiveness in experimental potassium depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Effect of adrenergic blocking agents on insulin response to glucose infusion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Adrenergic Modulation of Basal Insulin Secretion in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Ursachen der St�rungen im Kohlenhydratstoffwechsel unter dem Einflu� sulfonamidierter Diuretica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Effect of Diazoxide on Glucose U-C-14 Utilization in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Adrenergic mechanisms of catecholamine action on glucose homeostasis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Increased Plasma Levels of Growth Hormone During Infusion of Propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

The Insulin Resistance of Acromegaly: Evidence for Two Alterations in the Insulin Receptor on Circulating Monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Acute Metabolic Effects of Human Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

The Effect of Diabetic Control on the Width of Skeletal-Muscle Capillary Basement Membrane in Patients with Type I Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

Drug-induced reversal of early diabetic microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991900-2

7 January 2021

10.1016/S0140-6736(85)91900-2

Identifiers

DOI

1 reference

release_kdln2tulmvfmngsusda3hxv67e

18 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kdln2tulmvfmngsusda3hxv67e

24 November 2022

mapped directly with Wikidata item

1 reference